Genelabs Technologies 8-K 2007
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 8, 2007
Genelabs Technologies, Inc.
(Exact Name of Registrant as Specified in its Charter)
Registrants telephone number, including area code: (650) 369-9500
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Item 8.01. Other Events.
On February 8, 2007, Genelabs issued a press release announcing an agreement to raise $10.0 million in private placement financing. It will sell approximately 5.8 million shares of its common stock and warrants to purchase approximately 1.7 million shares of its common stock to institutional investors and accredited investors for $1.72 per share (which includes the warrant purchase price of $0.125 per share underlying the warrants), with a warrant exercise price of $1.85 per share. The full text of the Genelabs press release is furnished as Exhibit 99.1 hereto to this Current Report on Form 8-K, and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.